Although in our context, bacteria confer resistance to NAMPT inhibitors mainly via modulation of NAD+ metabolites, there is growing evidence indicating that host commensal microbiota can also modulate the efficacy of cancer therapy via other mechanisms that include immunomodulation, activation of autophagy, translocation, and drug metabolism [42–45]. Here, NAMPT is linked to cancer.